Cellular basis and clinical evaluation of antiarrhythmic therapy.
D000109:Acetylcholine / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001949:Bretylium Compounds / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects*; D004071:Digitalis Glycosides / Q000494:pharmacology; D006327:Heart Block / Q000188:drug therapy; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008564:Membrane Potentials / Q000187:drug effects; D010672:Phenytoin / Q000494:pharmacology; D011188:Potassium / Q000097:blood; D011342:Procainamide / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D002395:Catecholamines; D004071:Digitalis Glycosides; D010672:Phenytoin; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D000109:Acetylcholine; D011188:Potassium